Skip to main content
. Author manuscript; available in PMC: 2017 Jul 5.
Published in final edited form as: J Vaccines Vaccin. 2016 Oct 3;7(5):340. doi: 10.4172/2157-7560.1000340

Figure 2.

Figure 2

Minimum population immunity to transmission of each WPV serotype at tOPV or OPV13 cessation to prevent a subsequent homotypic cVDPV outbreak in the hypothetical population with an R0 for WPV1 equal to 13*.*R0 for WPV2 = 0.9 × R0 for WPV1 (i.e., 0.9 × 13=11.7) and R0 for WPV3=0.75 × R0 for WPV1 (i.e., 0.75 ×13=9.75)